tiprankstipranks
Trending News
More News >

Robert Bitterman Insider Profile

4 Followers
Robert Bitterman, Chairman, Pres. & CEO, Director at Phio Pharmaceuticals, holds 271.42K shares in Phio Pharmaceuticals (Ticker: PHIO), holds 0.00 shares in Fibrocell Science (Ticker: FCSC).
tipranks
Robert Bitterman

Robert Bitterman
Phio Pharmaceuticals (PHIO)
Chairman, Pres. & CEO, Director

Ranked #100,652 out of 103,606 Corporate Insiders

Profitable Transactions

8%
1 out of 13 Profitable Transactions

Average Return

-59.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$649K
100.00%
A breakdown of Robert Bitterman's holdings

Insider Roles

Phio Pharmaceuticals
(PHIO)
Chairman, Pres. & CEO, Director
Roles that Robert Bitterman holds in companies

Most Profitable Insider Trade

Stock:
Phio Pharmaceuticals
(PHIO)
Rating:Informative Buy
Date:May 23, 2025 - Today
Return:+18.20%
The most profitable trade made by Robert Bitterman

Robert Bitterman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Phio Pharmaceuticals
Sep 15, 2025
Chairman, Pres. & CEO, Director
Uninformative Buy
$648.70K
FCSC
Fibrocell Science
$0.00
List of latest transactions for each holding click on a transaction to see Robert Bitterman's performance on stock

Robert Bitterman insider profile FAQ

What is the percentage of profitable transactions made by Robert Bitterman?
The percentage of profitable transactions made by Robert Bitterman is 8%.
    What is the average return per transaction made by Robert Bitterman?
    The average return per transaction made by Robert Bitterman is -59.20%.
      What stocks does Robert Bitterman hold?
      Robert Bitterman holds: PHIO, FCSC stocks.
        What was Robert Bitterman’s latest transaction?
        Robert Bitterman latest transaction was an Uninformative Buy of ―.
          What was Robert Bitterman's most profitable transaction?
          Robert Bitterman’s most profitable transaction was an Informative Buy of PHIO stock on May 23, 2025. The return on the trade was 18.20%.
            What is Robert Bitterman's role in Phio Pharmaceuticals?
            Robert Bitterman's role in Phio Pharmaceuticals is Chairman, Pres. & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.